This episode featuring James Mackay, President & CEO of Aristea Therapeutics. James provides insights on his experience with setting up a biotech and challenges associated, industry climate on spin off opportunities, Aristea’s pipeline, collaborations and US PRMA reforms.
Presenter: Aparna Krishnan
Contributors: James Mackay, President & CEO of Aristea Therapeutics
Producer: Operations team
About Aristea Therapeutics, a San Diego-based clinical-stage immunology-focused drug development company developing novel therapies for serious, rare inflammatory diseases.
Weekly Roundup: August 16, 2018
Weekly Roundup: August 9, 2018
Weekly Roundup: August 2, 2018
Weekly Roundup: July 26, 2018
Weekly Roundup: July 17, 2018
Weekly Roundup: July 11, 2018
Weekly Roundup: July 4, 2018
Weekly Roundup: June 26, 2018
Weekly Roundup: June 19, 2018
Weekly Roundup: June 12, 2018
Weekly Roundup: June 5, 2018
Weekly Roundup: May 31, 2018
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Museum of the Missing
Strange by Nature Podcast
Sasquatch Chronicles
Hidden Brain